Tags

Type your tag names separated by a space and hit enter

Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
Travel Med Infect Dis. 2009 Jul; 7(4):231-4.TM

Abstract

The Islamic Hajj pilgrimage to Mecca, Saudi Arabia has historically been associated with outbreaks of serogroup A and W135 meningococcal disease. Prevention against meningococcal disease has principally been vaccination with meningococcal polysaccharide vaccines, either in a bivalent serogroup A/C or quadrivalent A/C/Y/W135 form. These interventions have suppressed meningococcal disease since 2002. Countries with large Muslim populations have now started to show a trend of increased serogroup B meningococcal disease, a serogroup for which there is no universal vaccine available. These trends should increase our preparedness to expect a sudden change in the etiology of meningococcal disease during the Hajj.

Authors+Show Affiliations

Medical Research, Ministry of Health, Riyadh, Saudi Arabia. statkhl@hotmail.comNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19717106

Citation

Khalil, Mohamed K M., and Ray Borrow. "Serogroup B Meningococcal Disease During Hajj: Preparing for the Worst Scenario." Travel Medicine and Infectious Disease, vol. 7, no. 4, 2009, pp. 231-4.
Khalil MK, Borrow R. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. Travel Med Infect Dis. 2009;7(4):231-4.
Khalil, M. K., & Borrow, R. (2009). Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. Travel Medicine and Infectious Disease, 7(4), 231-4. https://doi.org/10.1016/j.tmaid.2009.07.001
Khalil MK, Borrow R. Serogroup B Meningococcal Disease During Hajj: Preparing for the Worst Scenario. Travel Med Infect Dis. 2009;7(4):231-4. PubMed PMID: 19717106.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Serogroup B meningococcal disease during Hajj: preparing for the worst scenario. AU - Khalil,Mohamed K M, AU - Borrow,Ray, Y1 - 2009/08/11/ PY - 2009/07/07/received PY - 2009/07/14/revised PY - 2009/07/16/accepted PY - 2009/9/1/entrez PY - 2009/9/1/pubmed PY - 2009/12/23/medline SP - 231 EP - 4 JF - Travel medicine and infectious disease JO - Travel Med Infect Dis VL - 7 IS - 4 N2 - The Islamic Hajj pilgrimage to Mecca, Saudi Arabia has historically been associated with outbreaks of serogroup A and W135 meningococcal disease. Prevention against meningococcal disease has principally been vaccination with meningococcal polysaccharide vaccines, either in a bivalent serogroup A/C or quadrivalent A/C/Y/W135 form. These interventions have suppressed meningococcal disease since 2002. Countries with large Muslim populations have now started to show a trend of increased serogroup B meningococcal disease, a serogroup for which there is no universal vaccine available. These trends should increase our preparedness to expect a sudden change in the etiology of meningococcal disease during the Hajj. SN - 1873-0442 UR - https://www.unboundmedicine.com/medline/citation/19717106/Serogroup_B_meningococcal_disease_during_Hajj:_preparing_for_the_worst_scenario_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1477-8939(09)00120-3 DB - PRIME DP - Unbound Medicine ER -